Plant‐Derived Thylakoids Potentiate Copper‐Mediated Multimodal Cell Death via Hypoxia Alleviation for Synergistic Antitumor Therapy
Small · 2026
DOI: 10.1002/smll.74072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Wei Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Copper, Thylakoids, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Guangzhou Basic and Applied Basic Research Foundation, Stomatological Hospital of the Southern Medical University Startup Funds.
Abstract (Originalsprache)
Cuproptosis is a copper‐dependent programmed cell death mechanism characterized by mitochondrial copper accumulation, which leads to protein aggregation and proteotoxic stress, offering considerable anti‐cancer potential. However, the hypoxic tumor microenvironment (TME) activates HIF‐1α signaling, promoting glycolytic metabolism and reducing sensitivity to cuproptosis. To overcome this limitation, we designed TC@UN/G, a system comprising a metal–organic framework (UN) for copper delivery, oxygen‐generating thylakoids (T) to alleviate hypoxia via photosynthesis, and a thermosensitive F127 hydrogel (G) for localized sustained release through peritumoral injection. Upon peritumoral injection and light illumination, thylakoids produced oxygen, relieving hypoxia and restoring mitochondrial function. This sensitized tumor cells to cuproptosis and concurrently triggered ferroptosis and immunogenic cell death, thereby activating antitumor immunity. In the cancer model, TC@UN/G+IL suppressed tumor growth and remodeled the TME. This approach offers a holistic strategy for solid tumor therapy by modulating the TME, potentiating cuproptosis, and activating the immune response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
- The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan, Guangdong, China.
ORCID-Profile: Xiang Sun, Yuyue Zhao, Tongkai Chen, Guangtao Yu
Förderung
- National Natural Science Foundation of China
- Guangzhou Basic and Applied Basic Research Foundation
- Stomatological Hospital of the Southern Medical University Startup Funds
Zitieren
APA
Liu, W., Wu, J., Lan, Z., Ma, X., Sun, X., Cheng, G., Yang, Y., Li, B., Tian, Z., Yu, J., Zhu, Z., Luo, Q., Lin, Z., Chen, Y., Zhao, Y., Chen, T., & Yu, G. (2026). Plant‐Derived Thylakoids Potentiate Copper‐Mediated Multimodal Cell Death via Hypoxia Alleviation for Synergistic Antitumor Therapy. Small. https://doi.org/10.1002/smll.74072
Vancouver
Liu W, Wu J, Lan Z, Ma X, Sun X, Cheng G, et al. Plant‐Derived Thylakoids Potentiate Copper‐Mediated Multimodal Cell Death via Hypoxia Alleviation for Synergistic Antitumor Therapy. Small. 2026. doi:10.1002/smll.74072
BibTeX
@article{Liu2026,
author = {Liu, Wei and Wu, Jiaxin and Lan, Zhou and Ma, Xinqi and Sun, Xiang and Cheng, Guowang and Yang, Yumiao and Li, Bowen and Tian, Zhen and Yu, Jiaxian and Zhu, Zhiyang and Luo, Qibu and Lin, Zhenzi and Chen, Yingluo and Zhao, Yuyue and Chen, Tongkai and Yu, Guangtao},
title = {Plant‐Derived Thylakoids Potentiate Copper‐Mediated Multimodal Cell Death via Hypoxia Alleviation for Synergistic Antitumor Therapy},
journal = {Small},
year = {2026},
doi = {10.1002/smll.74072}
}
EUVIMED